Results 101 to 110 of about 98,169 (325)
The Laryngoscope, EarlyView.PET‐CT of the nasopharynx depicting not only intensive PET avidity in the right Rouvière lymph node (A: arrows) correlating with MRI findings but also increased FDG avidity at the level of the torus tubarius (B: arrows), on the right more than on the left and along the posterior nasopharyngeal wall.
Raffael Fink +4 more
wiley +1 more source
Editorial: Targeting glucose metabolism in cancer immunity and immunotherapy
Frontiers in Immunology, 2023 Olivier Feron +6 more
doaj +1 more source
World Journal of Nuclear Medicine, 2012 Glioblastoma multiforme (GBM) is the most common primary brain tumor in adults, and is generally of poor prognosis. The post-treatment assessment of GBMs is a known diagnostic issue, with problems in the differentiation of viable remnant tumor and post ...
Chjoong Howe Tan, Eik Hock Tan
doaj +1 more source
, 2009 Purpose of reviewIntestinal tuberculosis (TB) is increasing due partly to the HIV pandemic. Its clinical presentation mimics inflammatory conditions such as Crohn's disease and malignancies, which are becoming more prevalent, so the diagnosis is ...
Donoghue, HD, Holton, J
core +1 more source
Movement Disorders, EarlyView.Abstract Background Glial cell line–derived neurotrophic factor (GDNF) is required for development and survival of dopaminergic neurons. A previous trial evaluating lower‐dose adeno‐associated virus serotype 2–GDNF (AAV2‐GDNF) bilateral intraputaminal infusion in participants with advanced Parkinson's disease (PD) achieved 26% mean putaminal coverage ...
Amber D. Van Laar +10 more
wiley +1 more source
Applications of neuroimaging to disease-modification trials in Alzheimer's disease. [PDF]
, 2009 Critical to development of new therapies for Alzheimer's disease (AD) is the ability to detect clinical or pathological change over time. Clinical outcome measures typically used in therapeutic trials have unfortunately proven to be relatively variable ...
Aisen, Paul S +5 more
core +2 more sources
Tc-99m glucoheptonate is poor man′s fluorodeoxyglucose
Indian Journal of Nuclear Medicine, 2011 While fluoro-deoxy-glucose (FDG) has emerged as an important radiotracer for imaging tumors, myocardial viability and infection, the role of other glucose analogues should also be explored. Tc-99m Glucoheptonate (GHA) has been used for imaging brain tumors and lung tumors.
openaire +4 more sources
An interview with Ondřej Strýček, 2025 Epilepsia Open prize winner for clinical research
Epilepsia Open, EarlyView.
Merab Kokaia, Piero Perucca
wiley +1 more source
Movement Disorders, EarlyView.ABSTRACT Neuroimaging with positron emission tomography (PET) has been instrumental in elucidating neurobiological mechanisms behind therapeutical trials in Parkinson's disease (PD). A variety of medical and neurosurgical interventions have been evaluated using many radioligands that reveal molecular basis for target engagement and brain responses in ...
Vijay Dhawan +4 more
wiley +1 more source
Diagnostic and Interventional RadiologyPURPOSE: By correcting the effect of tumor size on metabolic activity, the maximum standardized uptake value-to-tumor size (SUVmax:tumor size) ratio on fluorodeoxyglucose F18 positron emission tomography (18F-FDG PET)/computed tomography (CT) scans can ...
Soo Jeong Kim +4 more
doaj +1 more source